Company Registration No. 15658604 (England and Wales)
Pharma Investment Ltd
Filleted Accounts
for the year ended 30 April 2025
Pharma Investment Ltd
Filleted Accounts
Contents
Pharma Investment Ltd
Company Information
for the year ended 30 April 2025
Directors
Mr Vaseem Mohammed Raziq
Mr Aadil Abdul Gaffar Mitha
Company Number
15658604 (England and Wales)
Registered Office
Orchard House
Bullsmoor
Belper
DE56 1JS
England
Accountants
YP Finance
Hawthorne House
17A Hawthorne Drive
Leicester
Leicestershire
LE5 6DL
Pharma Investment Ltd
Statement of financial position
as at 30 April 2025
Investment property
150,000
Cash at bank and in hand
2
Creditors: amounts falling due within one year
(1,030)
Net current liabilities
(1,028)
Total assets less current liabilities
148,972
Creditors: amounts falling due after more than one year
(152,475)
Called up share capital
10
Profit and loss account
(3,513)
Shareholders' funds
(3,503)
For the year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 1 December 2025 and were signed on its behalf by
Mr Vaseem Mohammed Raziq
Director
Company Registration No. 15658604
Pharma Investment Ltd
Notes to the Accounts
for the year ended 30 April 2025
Pharma Investment Ltd is a private company, limited by shares, registered in England and Wales, registration number 15658604. The registered office is Orchard House, Bullsmoor, Belper, DE56 1JS, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws.
Deferred tax assets and liabilities are not discounted.
Investment property is included at market fair value. Gains are recognised in the income statement. Deferred taxation is provided on these gains at the rate expected to apply when the property is sold.
Investments in shares are included at fair value.
Pharma Investment Ltd
Notes to the Accounts
for the year ended 30 April 2025
5
Creditors: amounts falling due within one year
2025
6
Creditors: amounts falling due after more than one year
2025
Loans from directors
152,475
Allotted, called up and fully paid:
100 Ordinary shares of £0.10 each
10
Shares issued during the period:
100 Ordinary shares of £0.10 each
10
8
Average number of employees
During the year the average number of employees was 0.